மேட்டர் ஆரோக்கியம் இல் குயின்ஸ்லாந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Advertisement People struck down by an extremely rare clotting disorder that has been associated with the AstraZeneca COVID-19 vaccine may take weeks to recover and more serious cases could require ongoing treatment. With so few cases detected globally, experts say people with the emerging and sometimes fatal syndrome are being treated on a case-by-case basis. A nurse holds a vial of the AstraZeneca COVID-19 vaccine, manufactured by the Serum Institute of India and provided through the global COVAX initiative, in Machakos, Kenya. Credit:AP Infectious diseases expert Professor Paul Griffin, who sits on Australia’s AstraZeneca advisory board, said: “Every case is essentially being treated on its merits because we just don’t have enough cases for there to be a robust protocol that ha been replicated over and over,”

United kingdomJose perdomoSutherland clinical schoolHaematology research unitMater health in queenslandAustralia therapeutic goods administrationEuropean medicines agencyBill renwickWestern healthMater healthTherapeutic goods administrationஒன்றுபட்டது கிஂக்டம்ஜோசே பெர்தோமோசதர்லேண்ட் மருத்துவ பள்ளிஹீமாட்டாலஜி ஆராய்ச்சி அலகுமேட்டர் ஆரோக்கியம் இல் குயின்ஸ்லாந்து